4.7 Article

Role of curcumin in the treatment of acute kidney injury: research challenges and opportunities

Journal

PHYTOMEDICINE
Volume 104, Issue -, Pages -

Publisher

ELSEVIER GMBH
DOI: 10.1016/j.phymed.2022.154306

Keywords

Acute kidney injury; Curcumin; Pharmacokinetics; Mitochondria; Nano formulations

Funding

  1. National Natural Science Foundation of China [31972889, 81300085]
  2. Natural Science of Guangdong Province [2017A030313571]
  3. Medical Science and Technology research Foundation of Guangdong Province [A2022063, 1050]
  4. Talents Cultivated Project of Jiangxi University of TCM [5142001004]

Ask authors/readers for more resources

Acute kidney injury (AKI) is a common complication in clinical inpatients, and current chemical drugs often have limited efficacy and toxic side effects in AKI treatment. Therefore, finding natural interventions, such as curcumin, is of great clinical significance. Curcumin, a natural phenolic compound, shows therapeutic effects in AKI by restoring renal function through multiple mechanisms. However, the low bioavailability of curcumin hinders its clinical application.
Background: Acute kidney injury (AKI) is a common complication in clinical inpatients, and it continues a high morbidity and mortality rate despite many clinical treatment measures. AKI is triggered by infections, surgery, heavy metal exposure and drug side effects, but current chemical drugs often fall short of expectations for AKI treatment and have toxic side effects. Therefore, finding new interventions and treatments, especially of natural origin, is of remarkable clinical significance and application. The herbal monomer curcumin is a natural phenolic compound extracted from the plant Curcuma longa and showed various biological activities, including AKI. Furthermore, recent studies have shown that curcumin restores renal function by modulating the immune system and the release of inflammatory mediators, scavenging oxygen free radicals, reducing apoptosis and improving mitochondrial dynamics. However, curcumin has a low bioavailability, which limits its clinical application. For this reason, it is essential to investigate the therapeutic effects and molecular mechanisms of curcumin in AKI, as well as to improve its bioavailability for curcumin formulation development and clinical application. Purpose: This review summarizes the sources, pharmacokinetics, and limitations in the clinical application of curcumin and explores methods to optimize its bioavailability using nanotechnology. In particular, the therapeutic effects and molecular mechanisms of curcumin on AKI are highlighted to provide a theoretical basis for AKI treatment in clinical practices. Methods: This review was specifically searched by means of a search of three databases (Web of Science, PubMed and Science Direct), till December 2021. Search terms were Curcumin, Acute kidney injury, AKI,

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.7
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available